Get the Stockscreener App
3.83
1.06%
0.04
Engene Holdings Inc stock is traded at $3.83, with a volume of 91,113.
It is up +1.06% in the last 24 hours and up +5.80% over the past month.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
See More
Previous Close:
$3.79
Open:
$3.74
24h Volume:
91,113
Relative Volume:
0.99
Market Cap:
$195.73M
Revenue:
-
Net Income/Loss:
$-103.21M
P/E Ratio:
-0.8326
EPS:
-4.6001
Net Cash Flow:
$-26.70M
1W Performance:
+3.51%
1M Performance:
+5.80%
6M Performance:
-42.84%
1Y Performance:
-56.53%
1-Day Range:
$3.67
$3.96
1-Week Range:
$3.45
$3.96
52-Week Range:
$2.65
$11.00
Engene Holdings Inc Stock (ENGN) Company Profile
Name
Engene Holdings Inc
Sector
Industry
Phone
(514) 332-4888
Address
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
Compare ENGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENGN
Engene Holdings Inc
|
3.83 | 193.69M | 0 | -103.21M | -26.70M | -4.6001 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-18-25 | Initiated | Piper Sandler | Overweight |
| Feb-14-25 | Downgrade | UBS | Buy → Neutral |
| Dec-23-24 | Initiated | H.C. Wainwright | Buy |
| Nov-27-24 | Initiated | Raymond James | Outperform |
| Nov-18-24 | Initiated | JMP Securities | Mkt Outperform |
| Aug-28-24 | Initiated | Oppenheimer | Outperform |
| Apr-22-24 | Initiated | Wells Fargo | Overweight |
| Apr-15-24 | Initiated | Guggenheim | Buy |
| Mar-28-24 | Initiated | UBS | Buy |
| Mar-08-24 | Initiated | Morgan Stanley | Overweight |
| Feb-20-24 | Initiated | Leerink Partners | Outperform |
View All
Engene Holdings Inc Stock (ENGN) Latest News
Can enGene Holdings Inc. recover in the next quarterFree Scalable Portfolio Growth Suggestions - Newser
enGene Holdings Inc. stock trend forecastLong-Term Trend Tracking and Signal Summary - Newser
How enGene Holdings Inc. stock performs during market volatilityFree Sector Based Breakout Stock Forecast - Newser
What makes enGene Holdings Inc. Equity Warrant stock price move sharplyDaily Trading Guidance With Low Risk - jammulinksnews.com
Using R and stats models for enGene Holdings Inc. Equity Warrant forecastingFree Buy Signal Based on Chart Analysis - Newser
Why is enGene Holdings Inc. Equity Warrant stock attracting strong analyst attentionRetirement Planning Signals To Watch Now - jammulinksnews.com
Will earnings trigger a reversal in enGene Holdings Inc. Equity WarrantRetirement Investment Outlook and Return Summary - Newser
Earnings visualization tools for enGene Holdings Inc.Secure Trading Strategy Based on Technical Analysis - Newser
Market reaction to enGene Holdings Inc.’s recent newsPrice Action Summary and Entry Strategy Guide - Newser
Technical signs of recovery in enGene Holdings Inc. Equity WarrantAI-Powered Stock Trend Movement Analysis - Newser
How to recover losses in enGene Holdings Inc. stockFree Strong Buy With Technical Confidence - Newser
What is enGene Holdings Inc. company’s growth strategyWealth Building Review With Proven Results - jammulinksnews.com
How strong is enGene Holdings Inc. Equity Warrant company’s balance sheetBreakout Stocks Tracker For Consistent Profits - jammulinksnews.com
What is the dividend policy of enGene Holdings Inc. Equity Warrant stockBreakout Stocks Strategy With Low Risk - jammulinksnews.com
enGene Holdings Inc. Equity Warrant Company Revenue and Profit Trends: A Deep DiveFree Reliable Alerts for Daily Stock Movers - Newser
Sectors Driving Future Growth for enGene Holdings Inc. StockRisk/Reward Optimization Entry Point Analysis - Newser
enGene Holdings Inc. Equity Warrant stock volume spike explainedLong Term Stock Growth Plan Suggestions - Newser
When is enGene Holdings Inc. stock expected to show significant growthStock Strategy Signals For Consistent Profits - jammulinksnews.com
Tools to assess enGene Holdings Inc. Equity Warrant’s risk profileFree Pattern Alert With ROI Driven Strategy - Newser
enGene Holdings Inc. Company Revenue and Profit Trends: A Deep DiveFree Fast Gaining Stock Screener Report - Newser
Institutional scanner results for enGene Holdings Inc. Equity WarrantLow Risk Stock Trade Opportunity Analysis - Newser
enGene Holdings Inc. Equity Warrant Reversal Rally May Surprise BearsNews Based Entry Opportunity Alerts Detected - metal.it
Why enGene Holdings Inc. stock attracts strong analyst attentionFree Smart Allocation Stock Pick Insights - Newser
Is enGene Holdings Inc. stock overhyped or has real potentialChart Breakout Buy Signal Detection Confirmed - beatles.ru
Published on: 2025-07-29 15:19:02 - metal.it
What makes enGene Holdings Inc. stock price move sharplyFree High Accuracy Alerts for ROI Traders - Newser
Does enGene Holdings Inc. stock pay reliable dividendsReal-Time Setup Summary with ROI Focus - Newser
Can enGene Holdings Inc. Rally Enough to Break EvenShort Term High Yield Stock Tips for Active Traders - metal.it
What are enGene Holdings Inc. Equity Warrant company’s key revenue driversSmart Portfolio Recommendation For Beginners - jammulinksnews.com
Traders Consider Averaging Down in enGene Holdings Inc.AI Based High Gain Watchlist Scanner Shared - metal.it
How many analysts rate enGene Holdings Inc. Equity Warrant as a “Buy”Low Risk Report For Consistent Profits - jammulinksnews.com
How volatile is enGene Holdings Inc. Equity Warrant stock compared to the marketMarket-leading growth rates - jammulinksnews.com
Does enGene Holdings Inc. Equity Warrant stock perform well during market downturnsBuild a portfolio that stands the test of time - jammulinksnews.com
Does enGene Holdings Inc. stock perform well during market downturnsMassive portfolio appreciation - jammulinksnews.com
How does enGene Holdings Inc. Equity Warrant compare to its industry peersBuild wealth faster with disciplined trading - jammulinksnews.com
Should I hold or sell enGene Holdings Inc. stock in 2025Free Daily Trading Room Entry - jammulinksnews.com
Can enGene Holdings Inc. recover in the next quarter Long-Term Growth Trend Summary With Confidence - Newser
Live market analysis of enGene Holdings Inc. Equity Warrant Momentum Detection with Entry Optimization - Newser
What catalysts could drive enGene Holdings Inc. Equity Warrant stock higher in 2025Maximize portfolio growth with expert advice - jammulinksnews.com
Engene Holdings Inc Stock (ENGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Engene Holdings Inc Stock (ENGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Forbion Growth Opportunities F | 10% Owner |
Sep 30 '24 |
Buy |
6.34 |
341,332 |
2,163,362 |
2,400,791 |
| Forbion Growth Opportunities F | 10% Owner |
Sep 27 '24 |
Buy |
5.97 |
41,639 |
248,699 |
2,059,459 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 01 '24 |
Buy |
6.44 |
35,279 |
227,158 |
2,436,070 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 07 '24 |
Buy |
6.55 |
11,844 |
77,531 |
2,469,833 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 02 '24 |
Buy |
6.37 |
10,153 |
64,697 |
2,446,223 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 04 '24 |
Buy |
6.54 |
5,997 |
39,242 |
2,457,989 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 03 '24 |
Buy |
6.48 |
5,769 |
37,397 |
2,451,992 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 08 '24 |
Buy |
6.60 |
800 |
5,278 |
2,470,633 |
| Cooper Ronald Harold Wilfred | Chief Executive Officer |
Sep 27 '24 |
Buy |
5.70 |
10,000 |
57,000 |
10,000 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):